Raymond James lowered the firm’s price target on Hologic (HOLX) to $90 from $95 and keeps an Outperform rating on the shares. Hologic’s print ...
Symbotic (SYM – Research Report) received a Hold rating and price target from Raymond James analyst Brian Gesuale yesterday. The company’s ...